Regulation of the MDM2‐p53 pathway by the ubiquitin ligase HERC2

Jesús García‐Cano(University of Castilla-La Mancha), José Luís Rosa(Institut d'Investigació Biomédica de Bellvitge)

Molecular Oncology

October 30, 2019

10.1002/1878-0261.12592

Cited by 62

Related Papers

The E3 Ubiquitin Protein Ligase HERC2 Modulates the Activity of Tumor Protein p53 by Regulating Its Oligomerization

|Journal of Biological Chemistry|2014|81

Progressive Purkinje Cell Degeneration in tambaleante Mutant Mice Is a Consequence of a Missense Mutation in HERC1 E3 Ubiquitin Ligase

|PLoS Genetics|2009|72

Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance

|Oncotarget|2015|49